Equasens Group announced a change in its Executive Committee with effect from 1 January 2024. Damien VALICONbecomes the new head of the Pharmagest Division: Damien VALICON, currently manager of the Medical Solutions Division, will now head up the Pharmagest Division. In this new role, he will be responsible for maintaining the commercial momentum of Pharmacie France and ASCA, supporting the growth of European subsidiaries (PHARMAGEST Belgium, PHARMAGEST Luxembourg, PHARMAGEST Italia and the recently created PHARMAGEST Germany), as well as the development of compliance solutions with MULTIMEDS and iMEDS, and the new ATOOPHARM e-learning business.

Dominique GOURSAUDis appointed as head of the Medical Solutions Division: Dominique GOURSAUD, currently Chief Strategy and Business Development Officer, will now head up the Medical Solutions Division. In this new capacity, he will continue to strengthen the Division's sales organization and develop its service offering. Noëlle STOULIG is appointed as the new head of Communications for the Equasens Group: Noëlle STOULIG, currently European Marketing Manager for the Pharmagest Division, is appointed Director of Communications for Equasens Group.

In this capacity, she will be responsible for spearheading the Group's global communications and brand strategy, both internally and externally. The missions of Grégoire DE ROTALIER, Deputy Chief Executive Officer and Manager of the Axigate Link Division, Nicolas LAFON, Manager of the Fintech Division, Franck FAVIER, Manager of the e-Connect Division, Frédérique SCHMIDT, Chief Financial Officer, and Sabrina GHARBI, Chief Human Resources Officer, remain unchanged.